MD SB196

Authorizes the Department of Public Safety and Correctional Services to establish medication review committees to determine whether psychotropic medication may be administered involuntarily to incarcerated individuals who refuse it in licensed mental health infirmaries within state correctional facilities.

Prohibits involuntary administration of psychotropic medication except in emergencies (imminent danger) or when a committee approves nonemergency administration after finding the individual has a mental disorder, is unable to function in general population, presents a danger to self or others, and no less restrictive alternatives exist.

Requires committees to consist of the regional chief psychiatrist, another psychiatrist, and a non-physician mental health professional, with an impartial lay advisor assigned to assist the incarcerated individual.

Grants incarcerated individuals procedural rights including at least 10 business days written notice, the right to attend committee meetings, present witnesses, ask questions, and appeal decisions through administrative hearings within 72 hours and circuit court within 14 days.

Limits involuntary medication approval to 90 days maximum, requires documentation of medication benefits and side effects every 15 days, and takes effect July 1, 2026.